ReviewGE Portuguese journal of gastroenterology
Endoscopic Vacuum Therapy: When and How to Use It?
Review in GE Portuguese journal of gastroenterology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Gastrointestinal (GI) transmural defects are potential life-threatening conditions that need timely diagnosis and multi-modality treatment. Currently, there is a wide spectrum of minimally invasive therapeutic options that can be used alone or in combination. Recently, endoscopic vacuum therapy (EVT) has been added to these endoscopic therapeutic options. Summary: EVT has been showing promising clinical success rates with an acceptable safety profile competing with endoscopic stents. Due to its capacity to control exudate and to create granulation tissue, EVT is probably the best treatment for large size or chronic defects, or those associated with large collections. Nevertheless, there is lack of evidence about the best approach for each type of defect. The treatment course should be selected considering clinical status, type of surgery, chronicity, location and size of the defect, associated infected tissue, and local expertise. Despite its therapeutic potential, new devices and technical improvements are needed to standardize the technique, overcome EVT-related technical difficulties, and reduce complications. Key Messages: EVT is a paradigm shift in the treatment of GI transmural defects by allowing minimally invasive treatment of complex defects and avoiding morbimortality related to surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.